Acella Pharmaceuticals, LLC is recalling one lot of Doxycycline Hyclate Tablets USP, 100 mg, totaling 4,680 bottles of 500 tablets each. Testing during storage found that the medication did not meet dissolution specifications, meaning the tablets may not break down properly in the body. This could result in less medication being absorbed, potentially making the antibiotic treatment less effective. These prescription tablets were distributed nationwide in the USA.
The failure to meet dissolution specifications may lead to reduced absorption of the antibiotic in the bloodstream. This can result in decreased clinical efficacy, potentially failing to treat the underlying bacterial infection as intended.
You have 2 options:
Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005. Recall #: D-0014-2026.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.